Beyond the Status Quo: Exploring the Future Impact of HBV Innovations

Nov 10 2025
Convention Center: Room 152, Level 1
12:30 PM - 2:00 PM

World Class Speakers

Jordan J Feld, MD, MPH, FAASLD
Industry Presenter

Jordan J Feld, MD, MPH, FAASLD

Toronto General Hospital
Mark Sulkowski, MD, FAASLD
Industry Presenter

Mark Sulkowski, MD, FAASLD

Johns Hopkins Medicine
Grace Lai-Hung Wong, MD, MBChB (Hons), FRCP, FHKCP, FHKAM
Industry Presenter

Grace Lai-Hung Wong, MD, MBChB (Hons), FRCP, FHKCP, FHKAM

The Chinese University Of Hong Kong

Description

This engaging symposium will provide insights into recent innovations in the management of chronic hepatitis B. Expert faculty will discuss emerging biomarkers, investigational therapies aimed at chronic viral suppression and functional cure, and how these advances may help address existing gaps in care and improve long-term patient outcomes.

Supported by: Aligos Therapeutics
Organized by: Clinical Care Options, LLC

For more information and to register, visit: https://clinicaloptions.com/events/hbv-innovations/hbv-innovations/22094-36992

Journey Maps

Objectives

  • Evaluate the limitations of current antiviral therapy for HBV.<br>
  • Outline the role of emerging biomarkers in evaluating disease status and treatment response for patients with HBV.
  • Examine the role of emerging agents for chronic HBV suppression and their potential to improve patient outcomes.